Circulating cell-free TERT mRNA levels have been found to be higher in cancer patients with respect to controls, as well as independent markers of tumor response, and prognostic of disease progression in cancers frequently presenting with high tumor mass, e.g. gastric and colorectal cancer25,34,35. This evidence concerns the gene TERT and cancer.